Policymakers try to balance access, quality in TAVR
A new era in aortic stenosis treatment is off to a messy start as debate continues over just how dispersed transcatheter aortic valve replacement (TAVR) should be throughout the U.S., following June's final ruling by the Centers for Medicare & Medicaid Services (CMS) to implement new volume requirements for TAVR centers seeking reimbursement.